- Browse
- David Liu
- Nelson et al
- pU6-tevopreq1-GG-acceptor
- Citations
pU6-tevopreq1-GG-acceptor Citations (13)
Originally described in: Engineered pegRNAs improve prime editing efficiency.Nelson JW, Randolph PB, Shen SP, Everette KA, Chen PJ, Anzalone AV, An M, Newby GA, Chen JC, Hsu A, Liu DR Nat Biotechnol. 2021 Oct 4. pii: 10.1038/s41587-021-01039-7. doi: 10.1038/s41587-021-01039-7. PubMed Journal
Articles Citing pU6-tevopreq1-GG-acceptor
Showing 1 to 10 of 13 entries
Articles |
---|
Articles |
---|
Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells.
Bulcaen M, Kortleven P, Liu RB, Maule G, Dreano E, Kelly M, Ensinck MM, Thierie S, Smits M, Ciciani M, Hatton A, Chevalier B, Ramalho AS, Casadevall I Solvas X, Debyser Z, Vermeulen F, Gijsbers R, Sermet-Gaudelus I, Cereseto A, Carlon MS.
Cell Rep Med. 2024 May 21;5(5):101544. doi: 10.1016/j.xcrm.2024.101544. Epub 2024 May 1.
PubMed
Associated Plasmids |
Precise editing of pathogenic nucleotide repeat expansions in iPSCs using paired prime editor. Hwang HY, Gim D, Yi H, Jung H, Lee J, Kim D. Nucleic Acids Res. 2024 Jun 10;52(10):5792-5803. doi: 10.1093/nar/gkae310. PubMed |
Massively parallel screen uncovers many rare 3' UTR variants regulating mRNA abundance of cancer driver genes. Fu T, Amoah K, Chan TW, Bahn JH, Lee JH, Terrazas S, Chong R, Kosuri S, Xiao X. Nat Commun. 2024 Apr 18;15(1):3335. doi: 10.1038/s41467-024-46795-7. PubMed |
Enhancing prime editor activity by directed protein evolution in yeast. Weber Y, Bock D, Ivascu A, Mathis N, Rothgangl T, Ioannidi EI, Blaudt AC, Tidecks L, Vadovics M, Muramatsu H, Reichmuth A, Marquart KF, Kissling L, Pardi N, Jinek M, Schwank G. Nat Commun. 2024 Mar 7;15(1):2092. doi: 10.1038/s41467-024-46107-z. PubMed |
Prime-Editing of human ACTB in induced pluripotent stem cells to model human ACTB Loss-of-Function diseases and compensatory mechanisms. Binder S, Ramachandran H, Hildebrandt B, Dobner J, Rossi A. Stem Cell Res. 2024 Mar;75:103304. doi: 10.1016/j.scr.2024.103304. Epub 2024 Jan 3. PubMed |
Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a Myopathy. Godbout K, Rousseau J, Tremblay JP. Cells. 2023 Dec 22;13(1):31. doi: 10.3390/cells13010031. PubMed |
Benzomorphan and non-benzomorphan agonists differentially alter sigma-1 receptor quaternary structure, as does types of cellular stress. Couly S, Yasui Y, Foncham S, Grammatikakis I, Lal A, Shi L, Su TP. Cell Mol Life Sci. 2024 Jan 9;81(1):14. doi: 10.1007/s00018-023-05023-z. PubMed |
Flow cytometry-based quantification of genome editing efficiency in human cell lines using the L1CAM gene. Hasan MN, Hyodo T, Biswas M, Rahman ML, Mihara Y, Karnan S, Ota A, Tsuzuki S, Hosokawa Y, Konishi H. PLoS One. 2023 Nov 9;18(11):e0294146. doi: 10.1371/journal.pone.0294146. eCollection 2023. PubMed |
CRISPR prime editing for unconstrained correction of oncogenic KRAS variants.
Jang G, Kweon J, Kim Y.
Commun Biol. 2023 Jun 30;6(1):681. doi: 10.1038/s42003-023-05052-1.
PubMed
Associated Plasmids |
Prime editing strategies to mediate exon skipping in DMD gene. Happi Mbakam C, Roustant J, Rousseau J, Yameogo P, Lu Y, Bigot A, Mamchaoui K, Mouly V, Lamothe G, Tremblay JP. Front Med (Lausanne). 2023 May 25;10:1128557. doi: 10.3389/fmed.2023.1128557. eCollection 2023. PubMed |
If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.